StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
48
This year
2
Publishing Date
2024 - 02 - 27
1
2024 - 01 - 30
1
2023 - 12 - 05
1
2023 - 11 - 07
2
2023 - 11 - 06
1
2023 - 09 - 12
1
2023 - 08 - 15
1
2023 - 08 - 03
1
2023 - 06 - 27
2
2023 - 06 - 20
1
2023 - 05 - 23
1
2023 - 05 - 10
1
2023 - 03 - 29
1
2023 - 02 - 28
1
2022 - 12 - 13
1
2022 - 12 - 12
1
2022 - 11 - 15
1
2022 - 09 - 27
1
2022 - 08 - 16
1
2022 - 08 - 10
2
2022 - 08 - 08
1
2022 - 07 - 05
1
2022 - 06 - 11
1
2022 - 06 - 10
2
2022 - 05 - 17
1
2022 - 05 - 11
1
2022 - 04 - 13
2
2022 - 03 - 30
1
2022 - 02 - 22
1
2021 - 12 - 14
1
2021 - 12 - 11
1
2021 - 11 - 16
1
2021 - 11 - 10
1
2021 - 09 - 21
1
2021 - 09 - 19
1
2021 - 08 - 17
1
2021 - 08 - 11
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 05 - 26
1
2021 - 05 - 11
1
2021 - 05 - 05
1
2021 - 03 - 02
1
Sector
Communications
1
Health technology
48
Manufacturing
1
N/a
1
Tags
Abbvie
2
Antibody
2
Biotech-bay
2
Business
1
Cancer
1
Cd20
5
Clinical-trials-phase-i
1
Clinical-trials-phase-ii
1
Clinical-trials-phase-iii
1
Conference
1
Darzalex
1
Duobody
5
Earnings
1
Employee
13
Europe
2
Financial
6
Financial results
3
Lancet
1
Money
1
N/a
39
Phase 1
3
Phase 2
3
Phase 3
1
Positive
2
Results
23
Study
1
Symposium
1
Therapeutics
1
Therapy
1
Topline
4
Treatment
1
Trial
7
Update
4
Year
1
Entities
Abbvie inc.
12
Adc therapeutics sa
3
Amgen inc.
2
Arvinas, inc.
1
Astellas pharma inc
1
Biontech se
5
Bolt biotherapeutics inc
3
Bristol-myers squibb company
2
Genmab a/s
48
Halozyme therapeutics, inc.
1
Johnson & johnson
11
Karuna therapeutics, inc.
1
Matinas biopharma holdings, inc.
1
Medies
1
Mirati therapeutics, inc.
1
Novartis ag
6
Novocure limited
1
Orange
1
Pfizer, inc.
2
Sanofi
2
Seagen inc.
4
Zai lab limited
1
Symbols
ABBV
92
AEM
51
ALNY
81
AMGN
55
APO
41
ARVL
197
AUY
47
BAM
54
BGNE
52
BMO
41
BMY
73
BNPQF
82
BNPQY
82
BNTX
54
BTG
44
CHRS
48
CYTK
44
DAO
46
ENB
42
FBIO
61
FNCTF
374
FRBA
95
GILD
55
GMAB
48
GOLD
50
INCY
77
IONS
43
JD
43
JKS
42
JNJ
247
LGND
46
LLY
219
LTUM
61
LXRX
41
MDT
45
MDWD
53
MPC
55
MPLX
53
MS
225
NEE
49
NEP
48
NTES
59
NVS
59
NVSEF
44
PAYD
198
PFE
64
PPRUF
89
PPRUY
89
PRVB
46
REGN
88
SNY
393
SNYNF
315
TAK
71
TEVJF
53
TK
49
TNK
48
TTOO
44
UAN
52
XNCR
42
XYF
104
Exchanges
Amex
1
Nasdaq
48
Nyse
22
Crawled Date
2024 - 02 - 27
1
2024 - 01 - 30
1
2023 - 12 - 05
1
2023 - 11 - 07
2
2023 - 11 - 06
1
2023 - 09 - 12
1
2023 - 08 - 15
1
2023 - 08 - 03
1
2023 - 06 - 27
2
2023 - 06 - 20
1
2023 - 05 - 23
1
2023 - 05 - 10
1
2023 - 03 - 29
1
2023 - 02 - 28
1
2022 - 12 - 13
1
2022 - 12 - 12
1
2022 - 11 - 15
1
2022 - 09 - 27
1
2022 - 08 - 16
1
2022 - 08 - 10
2
2022 - 08 - 08
1
2022 - 07 - 05
1
2022 - 06 - 11
1
2022 - 06 - 10
2
2022 - 05 - 17
1
2022 - 05 - 11
1
2022 - 04 - 13
2
2022 - 03 - 30
1
2022 - 02 - 22
1
2021 - 12 - 14
1
2021 - 12 - 11
1
2021 - 11 - 16
1
2021 - 11 - 10
1
2021 - 09 - 21
1
2021 - 09 - 19
1
2021 - 08 - 17
1
2021 - 08 - 11
1
2021 - 07 - 06
1
2021 - 06 - 22
1
2021 - 05 - 26
1
2021 - 05 - 11
1
2021 - 05 - 05
1
2021 - 03 - 02
1
Crawled Time
11:00
2
12:00
2
12:30
1
13:00
1
14:20
1
15:00
2
15:15
2
15:20
2
16:00
1
16:20
2
17:00
3
18:00
2
19:00
11
20:00
3
20:20
1
21:00
4
22:00
3
23:00
5
Source
www.biospace.com
9
www.globenewswire.com
36
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
results
symbols :
Gmab
save search
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Published:
2024-02-27
(Crawled : 21:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-3.83%
|
O:
-1.36%
H:
0.0%
C:
-4.56%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-1.79%
|
O:
-2.51%
H:
0.07%
C:
-2.3%
employee
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
Published:
2024-01-30
(Crawled : 12:30)
- biospace.com/
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
1.86%
|
O:
2.14%
H:
1.03%
C:
-0.89%
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-15.47%
|
O:
1.76%
H:
0.0%
C:
0.0%
ALPMY
|
$9.46
-1.11%
500K
|
Manufacturing
|
-19.48%
|
O:
-3.53%
H:
3.49%
C:
3.4%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-7.5%
|
O:
1.49%
H:
1.72%
C:
-3.12%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
0.85%
|
O:
0.42%
H:
0.04%
C:
-0.99%
ARVN
|
$34.3
2.54%
2.48%
800K
|
Health Technology
|
-15.43%
|
O:
-0.46%
H:
0.79%
C:
0.28%
financial
results
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Published:
2023-12-05
(Crawled : 23:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-10.43%
|
O:
1.42%
H:
2.7%
C:
0.28%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-8.82%
|
O:
2.84%
H:
0.68%
C:
-0.03%
employee
Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
Published:
2023-11-07
(Crawled : 21:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-3.35%
|
O:
6.62%
H:
2.29%
C:
-0.06%
ZLAB
|
News
|
$14.2
3.5%
3.38%
690K
|
Health Technology
|
-51.54%
|
O:
8.3%
H:
0.02%
C:
-2.12%
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
6.91%
|
O:
0.49%
H:
0.0%
C:
-0.57%
NVCR
|
$12.04
-0.08%
-0.08%
1.4M
|
Health Technology
|
-6.37%
|
O:
0.7%
H:
0.0%
C:
-6.94%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
4.89%
|
O:
0.29%
H:
0.21%
C:
-0.48%
KRTX
|
$329.83
0.0%
1.9M
|
Health Technology
|
83.73%
|
O:
0.27%
H:
0.14%
C:
-3.34%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-3.35%
|
O:
7.35%
H:
0.44%
C:
-2.18%
results
Genmab Announces Financial Results for the First Nine Months of 2023
Published:
2023-11-07
(Crawled : 16:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-1.5%
|
O:
0.39%
H:
4.92%
C:
1.52%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-0.4%
|
O:
0.24%
H:
0.18%
C:
0.16%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-4.55%
|
O:
0.18%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
15.61%
|
O:
-0.28%
H:
0.0%
C:
0.0%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-1.11%
|
O:
0.24%
H:
3.44%
C:
2.07%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-13.41%
|
O:
-0.35%
H:
3.09%
C:
3.03%
financial
results
BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
Published:
2023-11-06
(Crawled : 12:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-2.36%
|
O:
0.24%
H:
3.29%
C:
-1.11%
SNYNF
|
News
|
$92.7
-2.18%
1.4K
|
Health Technology
|
2.04%
|
O:
0.16%
H:
0.0%
C:
0.0%
PFE
A
|
$25.39
-0.12%
-0.12%
36M
|
Health Technology
|
-18.68%
|
O:
0.19%
H:
0.29%
C:
-0.45%
SNY
|
News
|
$45.395
-1.55%
-1.58%
4.4M
|
Health Technology
|
1.16%
|
O:
0.21%
H:
0.0%
C:
0.0%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-1.93%
|
O:
0.55%
H:
0.44%
C:
-1.37%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-9.86%
|
O:
5.74%
H:
3.18%
C:
-1.55%
update
financial
results
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Published:
2023-09-12
(Crawled : 18:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-23.24%
|
O:
-1.23%
H:
1.88%
C:
1.24%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-22.77%
|
O:
-1.6%
H:
0.55%
C:
-0.11%
employee
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Published:
2023-08-15
(Crawled : 17:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-23.59%
|
O:
0.98%
H:
0.89%
C:
-0.81%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-23.51%
|
O:
-0.11%
H:
0.34%
C:
-0.19%
employee
Genmab Announces Financial Results for the First Half of 2023
Published:
2023-08-03
(Crawled : 15:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-27.86%
|
O:
0.24%
H:
1.29%
C:
1.29%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-14.26%
|
O:
0.66%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
9.74%
|
O:
-0.28%
H:
0.27%
C:
0.06%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-27.92%
|
O:
-2.25%
H:
1.87%
C:
1.52%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-17.76%
|
O:
-0.25%
H:
3.13%
C:
1.84%
financial
results
AbbVie and Genmab Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
Published:
2023-06-27
(Crawled : 23:00)
- prnewswire.com
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
23.62%
|
O:
0.0%
H:
0.43%
C:
-0.07%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-24.04%
|
O:
-1.28%
H:
0.97%
C:
0.86%
cd20
duobody
abbvie
positive
topline
trial
results
Genmab and AbbVie Announce Positive Topline Results from Phase 1/2 EPCORE™ NHL-1 Trial Evaluating Epcoritamab (DuoBody® CD3xCD20) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
Published:
2023-06-27
(Crawled : 23:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-25.61%
|
O:
0.91%
H:
0.0%
C:
-1.43%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
23.62%
|
O:
0.0%
H:
0.43%
C:
-0.07%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-24.04%
|
O:
-1.28%
H:
0.97%
C:
0.86%
cd20
duobody
abbvie
positive
topline
trial
results
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Published:
2023-06-20
(Crawled : 19:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-27.1%
|
O:
-4.22%
H:
5.82%
C:
3.93%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-25.74%
|
O:
-0.88%
H:
0.72%
C:
0.32%
employee
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Published:
2023-05-23
(Crawled : 19:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-32.4%
|
O:
-0.72%
H:
0.0%
C:
-1.04%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-31.75%
|
O:
-1.39%
H:
0.0%
C:
-1.31%
employee
Genmab Announces Financial Results for the First Quarter of 2023
Published:
2023-05-10
(Crawled : 14:20)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-29.55%
|
O:
0.92%
H:
0.54%
C:
-0.64%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
7.53%
|
O:
-1.24%
H:
0.0%
C:
0.0%
NVS
|
$92.57
-0.55%
0.0%
910K
|
Health Technology
|
-11.1%
|
O:
-1.03%
H:
0.26%
C:
0.01%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-10.11%
|
O:
0.09%
H:
0.48%
C:
0.28%
ABBV
|
News
|
$164.66
0.25%
-0.15%
4.5M
|
Health Technology
|
11.64%
|
O:
-0.21%
H:
0.32%
C:
-0.07%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-27.92%
|
O:
0.15%
H:
2.12%
C:
1.79%
BNTX
|
$86.19
-0.24%
-0.24%
580K
|
Health Technology
|
-17.52%
|
O:
-1.6%
H:
1.64%
C:
-0.39%
financial
results
Bolt Biotherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Published:
2023-03-29
(Crawled : 22:00)
- globenewswire.com
FNCTF
|
News
|
$11.0354
-20.84%
34K
|
Communications
|
-3.96%
|
O:
1.48%
H:
0.0%
C:
0.0%
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-24.66%
|
O:
0.0%
H:
1.69%
C:
1.42%
BOLT
|
$1.15
3.6%
3.48%
89K
|
|
-10.85%
|
O:
5.43%
H:
0.74%
C:
-1.47%
BMY
|
$48.3
0.96%
-0.1%
11M
|
Health Technology
|
-29.22%
|
O:
0.29%
H:
0.22%
C:
-0.26%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-24.06%
|
O:
0.37%
H:
0.05%
C:
-0.4%
business
year
update
financial
results
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Published:
2023-02-28
(Crawled : 20:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-24.71%
|
O:
0.74%
H:
0.38%
C:
-1.33%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-24.04%
|
O:
-0.72%
H:
1.37%
C:
-0.8%
employee
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Published:
2022-12-13
(Crawled : 21:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-39.29%
|
O:
-2.05%
H:
1.95%
C:
0.33%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-37.88%
|
O:
-1.09%
H:
1.86%
C:
0.92%
employee
Janssen Presents Efficacy and Subgroup Analyses from MAIA Study Showing Long-Term Results of DARZALEX® (daratumumab)-based Regimen in Newly Diagnosed, Transplant-Ineligible Multiple Myeloma
Published:
2022-12-12
(Crawled : 18:00)
- biospace.com/
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-37.86%
|
O:
1.4%
H:
2.59%
C:
-1.22%
JNJ
|
News
|
$145.74
0.67%
0.0%
9.3M
|
Health Technology
|
-17.62%
|
O:
0.12%
H:
1.09%
C:
1.07%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-37.3%
|
O:
0.09%
H:
3.47%
C:
2.83%
darzalex
results
study
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Published:
2022-11-15
(Crawled : 19:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-33.47%
|
O:
0.02%
H:
3.58%
C:
1.34%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-33.81%
|
O:
0.79%
H:
0.55%
C:
0.14%
employee
Capital Increase in Genmab as a Result of Employee Warrant Exercise
Published:
2022-09-27
(Crawled : 17:00)
- globenewswire.com
GNMSF
|
$281.02
3.83%
210
|
Health Technology
|
-9.99%
|
O:
4.98%
H:
0.0%
C:
-4.34%
GMAB
|
$28.32
-0.74%
-0.74%
240K
|
Health Technology
|
-9.49%
|
O:
1.11%
H:
1.29%
C:
-0.16%
employee
← Previous
1
2
3
Next →
Gainers vs Losers
64%
36%
Top 10 Gainers
AGBA
|
News
|
$1.02
155.0%
57.94%
120M
|
Finance
ZCMD
|
$2.86
108.76%
52.1%
2.3M
|
Commercial Services
INVO
|
$1.555
104.6%
51.13%
5M
|
Health Technology
ISPC
|
$0.437
105.16%
49.53%
37M
|
Professional, Scientific, and T...
WLGS
|
News
|
$0.92
84.0%
45.65%
1.6M
|
OST
|
$0.499
21.38%
45.26%
1.9M
|
XPON
|
News
|
$3.1
60.62%
37.74%
17M
|
TIRX
|
$0.7
44.39%
30.74%
58M
|
BNTC
|
News
|
$6.92
44.17%
30.64%
3.5M
|
Health Technology
GGE
|
$0.035
19.86%
29.3%
64M
|
Your saved searches
Save your searches and get alerts when important news are released.